HCCI research Kevin Kennedy was quoted in a Crain's New York Business story on hospital price transparency rules. From the article: "It was pretty clear that the $300 a day wasn't going to be that much of an incentive for hospitals to comply when you're talking about multi-million- or -billion-dollar businesses," said Kevin Kennedy, a researcher at the Health Care Cost Institute, ...
News
Media coverage of HCCI’s original research
For general media inquiries or to propose collaborative projects, please contact us
Jul
23
Jul
20
HCCI's research on insulin prices was featured in a USA Today article on COVID-19 vaccine misinformation. From the article: "Insulin prices nearly doubled in the U.S from 2012 to 2016, a 2019 report by the nonprofit Health Care Cost Institute found." Fact check: False claim links COVID-19 vaccine's price, effectiveness Even though almost all COVID-19 deaths are occurring among unvaccinated p...
Jul
09
HCCI's created a list of most common outpatient procedures used in an article on the difficulty of using hospital price transparency data. Effort to Decipher Hospital Prices Yields Key Finding: Don’t Try It at Home - News Nation USA A federal price transparency rule that took effect this year was supposed to give patients, employers and insurers a clearer picture of the true cost of https://...
Jun
29
USA Today: Walmart launching its own low-cost insulin to 'revolutionize' affordability for diabetics
HCCI's research on insulin prices was featured in USA Today. From the article: "The lower-cost insulin is being released by Walmart in response to surging costs for the treatment used for patients with diabetes. According to the Health Care Cost Institute, a non-profit organization which sheds light on health care spending, the average price for an insulin prescription nearly doubled from 2012 ($3...
Jun
29
HCCI's research on the price of insulin was featured in CNBC. From the article: "As the number of people with diabetes climbs, the cost of the 100-year-old drug has soared rather than fallen and drawn scrutiny from lawmakers. The annual cost of insulin for people with Type 1 diabetes in the U.S. nearly doubled from $2,900 in 2012 to $5,700 in 2016, according to the most recent data available...
By accepting you will be accessing a service provided by a third-party external to https://healthcostinstitute.org/
©
2021
Health Care Cost Institute Inc. Unless explicitly noted, the content on this website is licensed under a Creative Commons Attribution Non-Commercial No Derivatives 4.0 License